C. Blandizzi et al., Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan, BR J PHARM, 132(1), 2001, pp. 73-84
1 This study investigates the mechanisms accounting for the adverse choline
rgic effects of the antitumour drug irinotecan. The activity of irinotecan
and its active metabolite, 7-ethyl-10-hydroxy-camptothecin (SN-38), was ass
ayed in models suitable for pharmacological studies on cholinergic system.
2 Irinotecan moderately inhibited human or electric eel acetylcholinesteras
e activity, SN-38 had no effect, whereas physostigmine blocked both the enz
ymes with high potency and efficacy.
3 Irinotecan and SN-38 did not affect spontaneous or electrically-induced c
ontractile activity of human colonic muscle. Acetylcholine and dimethylphen
ylpiperazinium (DMPP) caused phasic contractions or relaxations, respective
ly. Physostigmine enhanced the motor responses elicited by electrical stimu
lation.
4 Although irinotecan and SN-38 did not modify the basal contractile activi
ty of guinea-pig ileum longitudinal muscle strips, irinotecan 100 muM moder
ately enhanced cholinergic twitch contractions. Acetylcholine or DMPP cause
d phasic contractions, whereas physostigmine enhanced the twitch responses.
Electrically-induced [H-3]-acetylcholine release was reduced by irinotecan
(100 muM) or physostigmine (0.1 muM).
5 Intravenous irinotecan stimulated gastric acid secretion in rats, but no
effects were obtained with SN-38, physostigmine or i.c.v. irinotecan. Hyper
secretion induced by irinotecan was partly prevented by ondansetron, and un
affected by capsazepine. In the presence of atropine, vagotomy and systemic
or vagal ablation of capsaicin-sensitive afferent fibres, irinotecan did n
ot stimulate gastric secretion.
6 The present results indicate that irinotecan and SN-38 do not act as spec
ific acetylcholinesterase blockers or acetylcholine receptor agonists. It i
s rather suggested that irinotecan promotes a parasympathetic discharge to
peripheral organs, mediated by capsaicin-sensitive vagal afferent fibres, a
nd that serotonin 5-HT3 receptors are implicated in the genesis of vago-vag
al reflex triggered by irinotecan.